Real-World Data (RWD) Vs. Real-World Evidence (RWE)

Advanced cloud technologies have enabled pharmaceutical and biotech companies to collect, store, and analyze a vast amount of data i.e., real-world data (RWD) and real-world evidence (RWE) for numerous purposes, such as health economics, pricing, unmet needs, discovery/pre-clinical processes, and clinical R&D. For readers unfamiliar with the difference in these forms of data, RWD refers to raw data from various sources like electronic health records, claims data, and other real-time monitoring technologies, while RWE is the analysis of RWD to explore pertinent research questions.

While RWD and RWE are very useful in clinical trials, the industry emphasizes the need for high-quality, accurate data, and the use of advanced analytic tools to ensure that the data also meets regulatory guidelines across the drug development timeline.

Access the full article to unearth the significance of RWE in healthcare research and the need for clear definitions and guidelines for accurate RWE generation.